STENHOUSE MARK received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/30/2023ACC: 0001209191-23-033022
Director
Since Mar 2020
+24K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9K
Price / share
—
Trade value
—
% of position
New position
5/25/2023
0.00→9K
Total
Net shares
+9K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2023 | A · Award | +9K | — | — | New position | 0.00 | 9K |
| Total | +9K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
11.72
Held after
15K
Exercisable
—
5/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/25/2023 | A · Award | +15K | 11.72 | — | 15K |